Vitamin D supplementation: upper limit for safety revisited?

Area of Science:

• Endocrinology
• Nutritional Science
• Public Health

Background:

• Vitamin D deficiency is a global health concern.
• Current guidelines suggest an upper safety limit of 4000 IU/day for vitamin D.
• Potential risks of vitamin D toxicity include hypercalcemia and soft tissue calcification.

Purpose of the Study:

• To re-evaluate the established upper safety limit for vitamin D supplementation.
• To investigate factors influencing the risk of adverse events associated with vitamin D intake.
• To clarify the therapeutic window for vitamin D and calcifediol.

Main Methods:

• Review of existing literature on vitamin D toxicity and adverse events.
• Analysis of dose-response relationships and influencing factors (age, sex, vitamin D status).
• Comparison of safety profiles for different vitamin D compounds and regimens.

Main Results:

• The risk of adverse events is not solely dose-dependent but influenced by treatment regimen, outcome, and individual patient characteristics.
• A previously accepted upper limit of 4000 IU/day may not universally guarantee safety.
• Lower doses (800-1000 IU/day vitamin D or 10 µg/day calcifediol) are considered safe for deficiency prevention/correction.

Conclusions:

• The therapeutic window for vitamin D supplementation may be narrower than commonly recognized.
• Long-term or intermittent high-dose vitamin D regimens carry potential harm and should be avoided.
• Personalized assessment of vitamin D status and risk factors is crucial for safe supplementation.